Delving into the Latest Updates on Shaanxi Zhengkang Pharmaceutical Chemical Co Ltd with Synapse

Overview

本试验的目的是按照国家食品药品监督管理总局（CFDA）有关规定，对西安力邦制药有限公司提供的美托法宗片（受试制剂）进行健康受试者人体单剂量、单次和多次口服给药的药代动力学试验研究，评价试验药物在人体全血中主要药代动力学参数，以及安全性。

[Translation]

The purpose of this study is to conduct a single-dose, single-dose and multiple-dose oral pharmacokinetic study on Metofazone Tablets (test preparation) provided by Xi'an Libang Pharmaceutical Co., Ltd. in healthy subjects in accordance with the relevant regulations of the State Food and Drug Administration (CFDA), and to evaluate the main pharmacokinetic parameters of the test drug in human whole blood, as well as its safety.

Start Date12 Nov 2014

Sponsor / Collaborator

Xi'an Libang Pharmaceutical Co. Ltd.

[+1]

100 Clinical Results associated with Shaanxi Zhengkang Pharmaceutical Chemical Co Ltd

Login to view more data

0 Patents (Medical) associated with Shaanxi Zhengkang Pharmaceutical Chemical Co Ltd

Login to view more data

100 Deals associated with Shaanxi Zhengkang Pharmaceutical Chemical Co Ltd

Login to view more data

100 Translational Medicine associated with Shaanxi Zhengkang Pharmaceutical Chemical Co Ltd

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data